Interested in co-investing?

Partner with Parkwalk

Parkwalk’s specialist focus and experienced team allow us to move quickly and deploy capital efficiently. We actively co-invest with other specialist funds and have built a trusted network of partners, co-investors and industry experts, giving us access to the highest-quality deal flow in UK university spinouts.

We invest from £250k to £10m per round, backing companies from early stage through to Series C and beyond. We look to follow our capital and support businesses over multiple rounds.

With over a decade of consistent performance, we’ve earned a reputation as a reliable, long-term partner. Parkwalk is the most co-invested fund in this asset class and deploys around £50m per year into the sector.

Transforming UK university research into global impact

Meet our companies

The companies we invest in are developing groundbreaking university research into successful businesses, spanning sectors including Life Sciences, AI, Quantum Computing, Advanced Materials, Genomics, CleanTech, Future of Mobility, MedTech and Big Data.

Where university innovation meets investor opportunity

Team

With over 160 years experience, the investment team is well versed in all things venture capital and M&A.

From lab to market

Investment Strategy

Parkwalk bridges the funding gap between early academic discovery and later-stage venture capital. We invest across the spinout lifecycle – from seed to scale – helping turn pioneering research into commercial success.

As part of IP Group plc, we back companies from start-up to scale-up, with a proven record of delivering consistent investor returns.

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.